Annals of Geriatric Medicine and Research10.4235/agmr.20.0082202125133-38Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker TestsHankyung Jun, Sang Kyu Cho, Joanne Yoong, Soeren Mattke,,
Korean Journal of Pediatrics10.3345/kjp.2014.57.3.1102014573110Clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in KoreaYoung-Ho Lee
Brain10.1093/brain/awaa46220211442355-356Blood tests to screen for Alzheimer’s diseaseMasud Husain,
Alzheimer's & Dementia10.1002/alz.046027202016S4Blood‐cell‐based biomarker detection of Alzheimer’s diseaseRichard O Cliff,
2020 IEEE International Conference on Healthcare Informatics (ICHI)10.1109/ichi48887.2020.93743432020Stratification of patients with Alzheimer’s disease based on longitudinal neuropsychological testsStefanie Ziegler, Christoph Maier, Alexandra Reichenbach
Biomarkers for Preclinical Alzheimer’s Disease10.1007/978-1-4939-7674-4_172018249-258The Ethics of Biomarker-Based Preclinical Diagnosis of Alzheimer’s DiseaseAlexander F. Kurz, Nicola T. Lautenschlager
Journal of Pharmaceutical and Biomedical Analysis10.1016/j.jpba.2018.03.0162018154227-235A novel silanization agent based single used biosensing system: Detection of C-reactive protein as a potential Alzheimer’s disease blood biomarkerMünteha Nur Sonuç Karaboğa, Mustafa Kemal Sezgintürk,
Biomarker - Indicator of Abnormal Physiological Process10.5772/intechopen.766332018Topological Biomarker of Alzheimer’s DiseaseSanja Josef Golubic
Evidence-based Healthcare10.1054/ebhc.2000.031620004239Rivastigmine gives marginal improvement for people with Alzheimer’s diseaseJames P. Warner,
Alzheimer's Research & Therapy10.1186/s13195-021-00941-12022141Model-based stratification of progression along the Alzheimer disease continuum highlights the centrality of biomarker synergiesMuhammad Usman Sadiq, Kichang Kwak, Eran Dayan,,,